Electroencephalograph for Detection of Acute Ischemic Stroke

Overview

The purpose of this study is Collecting data for an Electroencephalograph based algorithm for detection of onset and deterioration of Acute Ischemic Stroke by Comparison to NIHSS.

Full Title of Study: “Collecting Data for an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective

Detailed Description

Inclusion criteria study population Age > 18 years old. Acute stroke symptoms onset within 120 hours of inclusion, and as proximate to event as possible. Acute ischemic moderate or severe hemispheric stroke (assessed as 5 points or more by NIHSS) and including patients treated by t-PA Exclusion criteria study population Primary intracranial hemorrhage on admission by CT. Significant movement disorder. Previous major hemispheric stroke. Local skull or skin affliction which prevents electrodes application. Any known condition which in the opinion of the investigator may interfere with the protocol implementation. Inclusion criteria Control Population Age > 18 years old. Exclusion criteria Control Population Primary intracranial hemorrhage on admission by CT. Significant movement disorder. Previous major hemispheric stroke. Local skull or skin affliction which prevents electrodes application. Migraine Any known condition which in the opinion of the investigator may interfere with the protocol implementation.

Interventions

  • Device: Neurokeeper stroke detector
    • Monitoring stroke patients

Arms, Groups and Cohorts

  • Study population
    • Stroke patients

Clinical Trial Outcome Measures

Primary Measures

  • Detection of stroke

Secondary Measures

  • Correlation to severity of stroke

Participating in This Clinical Trial

Inclusion Criteria

  • Age > 18 years old. – Acute stroke symptoms onset within 120 hours of inclusion, and as proximate to event as possible. – Acute ischemic moderate or severe hemispheric stroke (assessed as 5 points or more by NIHSS) and including patients treated by t-PA Exclusion Criteria:

  • Primary intracranial hemorrhage on admission by CT. – Significant movement disorder. – Previous major hemispheric stroke. – Local skull or skin affliction which prevents electrodes application. – Any known condition which in the opinion of the investigator may interfere with the protocol implementation

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Neurokeeper Technologies
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Shay Bar Haim, Msc, 972506822824, shaybarhaim@neurokeeper.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.